Medtronic, Inc.
Medtronic’s CoreValve Shows Subclavian Access Success in Patients Contraindicated for Femoral Approach
Published in Healthcare Finance, Tax and Law Weekly, June 10th, 2009
Medtronic, Inc. (NYSE: MDT) announced new data presented today on the safety and effectiveness of Medtronic’s CoreValve system via a novel, subclavian approach. The data reported procedural success of 100 percent; 24-hour survival of 100 percent; and 30-day survival of 89 percent. The available 30-day analysis also demonstrated clinical improvement in heart failure symptoms with 76 percent of the patients gaining at least a one-stage NYHA class and one-third improving by at least two stages.
Medtronic’s market-leading CoreValve system was designed to allow the implant of a replacement heart valve in patients with aortic stenosis who are at high or prohibitive surgical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Acacia Research Corporation
Acacia Subsidiary Enters into License Agreement with KYRSAGIH BROS. LIMITED LIABILITY COMPANY - Accelrys, Inc.
Accelrys Announces Fourth Quarter and Full Year Fiscal 2009 Financial Results - ACS
ACS Develops E-prescribing Capability for Alabama Medicaid - ACS
ACS’ Lora Villarreal Receives 2009 National Hispanic Woman of the Year Award - Acusphere, Inc.
Acusphere, Inc. Announces Prepayment of Equipment Loans - Addiction Medicine
New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
